Graphic of a human brain
neurocognitive

Neurocognitive Disease Research

Our neurocognitive disease research program investigates the underlying causes and potential treatment for conditions that affect cognitive function and neurological processes.

Play Video

Finding the causes of and cures for a variety of neurocognitive diseases.

We aim to identify the genetic and epigenetic causes of neurocognitive ailments with the hopes of developing cutting-edge treatments and cures. Currently, our team is working to identify causal factors associated with the development of autism, Alzheimer’s disease, Parkinson’s disease and post-traumatic stress disorder (PTSD).

Alzheimer's disease is a progressive neurological disorder that leads to the gradual degeneration and death of brain cells. It is the most common cause of dementia, a general term for cognitive decline that interferes with daily life. Alzheimer’s disease affects memory, thinking and behavior, and its symptoms worsen over time.

Research Labs Working on
Neurocognitive Disease Research

Kessinger Lab

The Kessinger Lab is at the cutting edge of developing molecular imaging techniques aimed at identifying novel biomarkers for PTSD. These targeted biomarkers are designed to enhance the detection, diagnosis and treatment of PTSD, helping to address the condition’s complex symptoms more effectively.

Kontaridis Lab

The Kontaridis Lab is dedicated to advancing our understanding of the genetic causes of autism by evaluating the genetic sequences of family members with generational cases of autism. Her lab is also working to identify a link between onset of congenital heart diseases and autism. Finally, the lab is working to assess the phenotype:genotype correlations of autism in the Upstate NY area. In partnership with several autism foundations, her lab is working to identify a link between genetic, environmental and socioeconomic determinants to the development of autism.

McCarthy Lab

The McCarthy Lab employs innovative molecular imaging and precision-targeted drug delivery methods to explore Alzheimer’s disease. By focusing on these advanced techniques, Dr. McCarthy seeks to improve the understanding and treatment of the neurodegenerative processes underlying Alzheimer’s, paving the way for more effective therapies.

News About Our
Neurocognitive Disease Research

Science Spotlight: Dr. Nunes Santos & Miss Della Posta

Luana Nunes Santos, Ph.D., postdoctoral fellow and Ariana Della Posta, research assistant, under Maria Kontaridis, Ph.D., executive director, are working…

Read More

$300,000 Goes to Autism and Cardiac Research in Utica

Dr. Adife Gulhan Ercan-Sencicek is an instructor at the Masonic Medical Research Institute, and Dr. Maria Kontaridis is its executive…

Read More

MMRI Studying Link Between Heart Defects and Autism

Scientists in Utica are studying if there a connection between autism and congenital heart defects. The research is being done…

Read More

The Battle Within Foundation Donates $25,000 for PTSD Research

To better understand the cause and effect of post-traumatic stress disorder (PTSD), The Battle Within Foundation (BWF) announced a first…

Read More

Human Technologies Funds Autism Research at MMRI

In support of its mission to create employment for people with disabilities, Human Technologies, 2260 Dwyer Ave., recently donated $5,000…

Read More

Thank You

Hope for People with Autism Spectrum Disorder

“There is currently no cure for Autism Spectrum Disorder (ASD), but together, we can drive research forward to help individuals diagnosed with this disorder and find better and more effective ways to help their condition.”

- Dr. Maria Kontaridis